Quick Dispatch:
Your glp-1 small molecule agonist Design, synthesis, and biological evaluation of a small molecule oral agonist of the glucagon-like-peptide-1 receptor orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your glp-1 small molecule agonist Design, synthesis, and biological evaluation of a small molecule oral agonist of the glucagon-like-peptide-1 receptor ships.
Need Help?
Questions about glp-1 small molecule agonist Design, synthesis, and biological evaluation of a small molecule oral agonist of the glucagon-like-peptide-1 receptor, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glp-1 small molecule agonist Design, synthesis, and biological evaluation of a small molecule oral agonist of the glucagon-like-peptide-1 receptor in your area.
In the ACHIEVE-1 phase 3 trial, the oral small-molecule GLP-1 receptor agonist orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with early type 2 diabetes
26.09
BioWorld
25.62
Structural basis of peptidomimetic agonism revealed by small-molecule GLP-1R agonists Boc5 and WB4-24
27.03
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity November 5, 2025 DOI: 10.1056/NEJMdo008238 New for the treatment of obesity - and so many additional indications being studied
21.94
GLP-1R Agonist DMB | Glucagon Receptor
23.58
What is GLP-1 and Its Receptor Agonists?
26.54
Figure 1 from Small Molecule Drug Discovery at the Glucagon-Like Peptide-1 Receptor
22.33
